X0303 4 2011-01-31 0 0001047699 KING PHARMACEUTICALS INC KG 0001500210 Bailey Jeffrey Allen 501 FIFTH STREET BRISTOL TN 37620 0 1 0 0 Chief Commercial Officer Common Stock 2011-01-31 4 D 0 40000 D 0 D Stock Option (Right to Buy) 8.75 2011-01-31 4 J 0 40000 D 2020-08-30 Common Stock 40000 0 D Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2010, among Pfizer Inc. ("Pfizer"), King Pharmaceuticals, Inc. and Parker Tennessee Corp. ("Acquisition Sub") (the "Merger Agreement"), these restricted shares, whether or not vested, were fully vested immediately prior to and canceled immediately following Acquisition Sub's acceptance of the common stock tendered and not validly withdrawn in accordance with the Tender Offer Statement on Schedule TO filed with the SEC by Pfizer and Acquisition Sub on October 22, 2010, as amended (the "Acceptance Time") in exchange for the right to receive cash payment for each restricted share of $14.25, net to the seller in cash, without interest and less any required withholding taxes. Pursuant to the the Merger Agreement these restricted shares, whether or not vested, were fully vested immediately prior to and canceled immediately following the Acceptance Time in exchange for the right to receive cash payment for each such restricted share of $14.25, net to the seller in cash, without interest and less any required withholding taxes. Pursuant to the Merger Agreement, these stock options, whether or not vested, were fully vested immediately prior to and canceled immediately following the Acceptance Time in exchange for the right to receive cash payment for each such option of the excess of $14.25 per option, net to the seller in cash, without interest and less any required withholding taxes, over the per-share exercise price of such option. /s/ Jeffrey A. Bailey 2011-02-02